Guardant Health GH Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 64.9%+0.4pp | 64.5%+0.7pp | 63.8%+0.9pp | 62.8%+1.5pp | 61.3%+0.6pp | |
| Operating margin | -41.4%+3.1pp | -44.5%+4.5pp | -49%+6.6pp | -55.6%+3.2pp | -58.8%+1.2pp | |
| Net margin | -40.1%+2.3pp | -42.4%+1.8pp | -44.2%+5.7pp | -49.9%+3.9pp | -53.8%+5.2pp | |
| Returns | ||||||
| Return on invested capital | -132.8%-81.0pp | -51.8%— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.1× | 0.6×-0.1× | 0.6×+0.1× | 0.6×+0.1× | 0.5×+0.1× | |
| Liquidity | ||||||
| Current ratio | 4.7×-0.2× | 4.8×+1.3× | 3.5×-0.2× | 3.7×-0.4× | 4.1×-0.6× | |
| Per Share | ||||||
| Book value per share | -$1.38-74.1% | -$0.79+72.1% | -$2.84-15.4% | -$2.46-21.6% | -$2.02-78.0% | |
| Valuation | ||||||
| Market capitalization | $12.12B-8.7% | $13.27B+70.3% | $7.79B+25.8% | $6.19B+17.8% | $5.26B+39.3% | |
| Price / sales | 11.2×-2.3× | 13.5×+4.9× | 8.6×+1.2× | 7.5×+0.7× | 6.8×+1.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Guardant Health's profit margins?
- Guardant Health (GH) runs a 64.9% gross margin and a -41.4% operating margin, with a -40.1% net margin.
- Where do Guardant Health's ratios come from?
- Every ratio is computed from Guardant Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
